pathway,nums,percent,pvalue
Alzheimer's disease,175,0.24,0.0
Non-alcoholic fatty liver disease (NAFLD),151,0.2913907284768212,0.0
Oxidative phosphorylation,151,0.1986754966887417,0.0
Parkinson's disease,144,0.2777777777777778,0.0
"Ribosome, eukaryotes",98,0.12244897959183673,0.0
Toll-like receptor signaling pathway,104,0.2692307692307692,0.0
Alzheimer disease,383,0.17493472584856398,0.0
Diabetic cardiomyopathy,211,0.35545023696682465,0.0
Cardiac muscle contraction,87,0.22988505747126436,0.001
Huntington's disease,194,0.17525773195876287,0.001
Metabolic pathways,1315,0.22889733840304183,0.001
Chemical carcinogenesis - reactive oxygen species,223,0.24663677130044842,0.001
Toxoplasmosis,109,0.3669724770642202,0.001
Immunoproteasome,18,0.6111111111111112,0.003
NOD-like receptor signaling pathway,220,0.2590909090909091,0.003
Type I diabetes mellitus,69,0.11594202898550725,0.003
TNF signaling pathway,115,0.3217391304347826,0.004
Leishmaniasis,70,0.3142857142857143,0.004
Arachidonic acid metabolism,95,0.042105263157894736,0.006
Pertussis,77,0.22077922077922077,0.007
Autoimmune thyroid disease,78,0.10256410256410256,0.007
Non-alcoholic fatty liver disease,156,0.28205128205128205,0.007
Cytokine-cytokine receptor interaction,326,0.1411042944785276,0.009
Epstein-Barr virus infection,230,0.27391304347826084,0.009
Allograft rejection,62,0.12903225806451613,0.009
Inflammatory bowel disease (IBD),59,0.2542372881355932,0.01
Thermogenesis,231,0.14285714285714285,0.01
Parkinson disease,264,0.1856060606060606,0.01
Antigen processing and presentation,97,0.1958762886597938,0.011
Graft-versus-host disease,62,0.12903225806451613,0.012
RIG-I-like receptor signaling pathway,73,0.3013698630136986,0.013
Inflammatory bowel disease,62,0.20967741935483872,0.013
HIF-1 signaling pathway,120,0.2,0.015
Jak-STAT signaling pathway,159,0.16981132075471697,0.015
Phagosome,192,0.1875,0.016
Carbon metabolism,126,0.023809523809523808,0.017
Alcoholic liver disease,141,0.2765957446808511,0.018
Herpes simplex infection,215,0.28837209302325584,0.02
Chagas disease,103,0.3106796116504854,0.02
Chagas disease (American trypanosomiasis),101,0.2871287128712871,0.021
Systemic lupus erythematosus,149,0.04697986577181208,0.021
Huntington disease,302,0.13245033112582782,0.022
Cytochrome c oxidase,25,0.28,0.025
Biosynthesis of amino acids,84,0.08333333333333333,0.026
NF-kappa B signaling pathway,114,0.2807017543859649,0.026
JAK-STAT signaling pathway,171,0.18128654970760233,0.027
Th1 and Th2 cell differentiation,89,0.23595505617977527,0.028
Toll-like receptor signaling,15,0.6,0.03
Legionellosis,60,0.15,0.03
Viral myocarditis,87,0.12643678160919541,0.031
Kaposi sarcoma-associated herpesvirus infection,223,0.29596412556053814,0.033
Hepatitis B,163,0.19631901840490798,0.035
Tuberculosis,180,0.2611111111111111,0.035
Cell adhesion molecules,182,0.12087912087912088,0.036
Primary immunodeficiency,36,0.25,0.037
Proteasome,47,0.2765957446808511,0.038
Polycomb repressive complex,84,0.08333333333333333,0.039
Adipocytokine signaling pathway,73,0.136986301369863,0.04
Lipid and atherosclerosis,216,0.2175925925925926,0.04
Hepatitis C,166,0.24096385542168675,0.042
PD-L1 expression and PD-1 checkpoint pathway in cancer,88,0.17045454545454544,0.043
Th17 cell differentiation,107,0.2336448598130841,0.044
Caffeine metabolism,6,0.5,0.045
Influenza A,173,0.3179190751445087,0.047
Prion disease,267,0.24344569288389514,0.047
Chemokine signaling pathway,204,0.23039215686274508,0.049
Cytosolic DNA-sensing pathway,80,0.2875,0.051
B cell receptor signaling pathway,85,0.24705882352941178,0.058
Apoptosis,137,0.3284671532846715,0.059
Cytochrome bc1 complex,10,0.3,0.059
Lysosome,136,0.19117647058823528,0.06
Hematopoietic cell lineage,98,0.10204081632653061,0.063
Measles,145,0.2689655172413793,0.063
Osteoclast differentiation,140,0.24285714285714285,0.064
Pathways of neurodegeneration - multiple diseases,471,0.22505307855626328,0.065
Cell adhesion molecules (CAMs),169,0.11834319526627218,0.07
Prolactin signaling pathway,74,0.0945945945945946,0.084
Mitophagy - animal,68,0.058823529411764705,0.088
Neutrophil extracellular trap formation,208,0.1201923076923077,0.088
Amyotrophic lateral sclerosis,369,0.23577235772357724,0.088
T cell receptor signaling pathway,125,0.16,0.092
Herpes simplex virus 1 infection,458,0.15938864628820962,0.092
Biosynthesis of cofactors,152,0.02631578947368421,0.094
"Fatty acid biosynthesis, elongation, endoplasmic reticulum",13,0.23076923076923078,0.095
Cocaine addiction,48,0.125,0.1
Fatty acid elongation,29,0.10344827586206896,0.103
IL-17 signaling pathway,93,0.25806451612903225,0.104
Necroptosis,175,0.2057142857142857,0.105
Intestinal immune network for IgA production,45,0.15555555555555556,0.116
Activin signaling,10,0.3,0.127
HTLV-I infection,283,0.1696113074204947,0.132
Tight junction,179,0.1564245810055866,0.133
C-type lectin receptor signaling pathway,112,0.2857142857142857,0.133
Viral life cycle - HIV-1,61,0.22950819672131148,0.138
Relaxin signaling pathway,129,0.17054263565891473,0.142
Rheumatoid arthritis,87,0.16091954022988506,0.145
Renin secretion,76,0.039473684210526314,0.148
Viral carcinogenesis,228,0.23684210526315788,0.149
Nucleotide metabolism,84,0.20238095238095238,0.163
Salmonella infection,253,0.31620553359683795,0.164
Glioma,74,0.13513513513513514,0.167
Viral protein interaction with cytokine and cytokine receptor,95,0.16842105263157894,0.171
Signaling pathways regulating pluripotency of stem cells,141,0.07801418439716312,0.172
Cell cycle - G1/S transition,13,0.3076923076923077,0.176
Natural killer cell mediated cytotoxicity,123,0.15447154471544716,0.176
Human T-cell leukemia virus 1 infection,249,0.20481927710843373,0.18
Prostate cancer,99,0.13131313131313133,0.183
Biosynthesis of unsaturated fatty acids,36,0.1111111111111111,0.193
Adrenergic signaling in cardiomyocytes,156,0.21794871794871795,0.198
RNA transport,167,0.39520958083832336,0.198
Exon junction complex (EJC),22,0.18181818181818182,0.2
Human immunodeficiency virus 1 infection,239,0.24686192468619247,0.202
Hypertrophic cardiomyopathy (HCM),84,0.03571428571428571,0.206
mRNA surveillance pathway,105,0.18095238095238095,0.214
Calcium signaling pathway,254,0.10236220472440945,0.232
Apelin signaling pathway,145,0.1724137931034483,0.248
DNA replication,35,0.45714285714285713,0.268
JAK-STAT signaling,19,0.2631578947368421,0.268
Hippo signaling pathway,158,0.12025316455696203,0.277
Thyroid cancer,37,0.08108108108108109,0.288
Fatty acid metabolism,64,0.078125,0.289
Breast cancer,147,0.09523809523809523,0.289
Basal cell carcinoma,63,0.047619047619047616,0.29
ErbB signaling pathway,86,0.05813953488372093,0.292
Dopaminergic synapse,138,0.036231884057971016,0.298
Small cell lung cancer,93,0.15053763440860216,0.298
FoxO signaling pathway,133,0.09022556390977443,0.299
EGFR tyrosine kinase inhibitor resistance,79,0.05063291139240506,0.299
Endometrial cancer,58,0.05172413793103448,0.301
Longevity regulating pathway,90,0.13333333333333333,0.308
"Aminoacyl-tRNA biosynthesis, eukaryotes",38,0.13157894736842105,0.312
Cellular senescence,183,0.19672131147540983,0.315
Drug metabolism - other enzymes,92,0.07608695652173914,0.317
Efferocytosis,155,0.16129032258064516,0.322
Endocytosis,297,0.16498316498316498,0.326
Protein processing in endoplasmic reticulum,183,0.08743169398907104,0.33
"RNA polymerase III, eukaryotes",18,0.16666666666666666,0.33
Amoebiasis,107,0.11214953271028037,0.334
Staphylococcus aureus infection,128,0.0625,0.335
Human cytomegalovirus infection,255,0.25098039215686274,0.336
Yersinia infection,135,0.21481481481481482,0.336
mmuK signaling pathway,301,0.1362126245847176,0.348
Oxytocin signaling pathway,154,0.14285714285714285,0.35
Cortisol synthesis and secretion,72,0.1111111111111111,0.353
Fluid shear stress and atherosclerosis,147,0.23129251700680273,0.371
Platinum drug resistance,80,0.15,0.375
Melanoma,72,0.09722222222222222,0.378
Ferroptosis,42,0.09523809523809523,0.381
Neurotrophin signaling pathway,121,0.19834710743801653,0.383
Other types of O-glycan biosynthesis,43,0.13953488372093023,0.386
Cushing syndrome,162,0.08024691358024691,0.394
Adherens junction,93,0.24731182795698925,0.404
Fanconi anemia pathway,51,0.058823529411764705,0.41
Autophagy - other,32,0.09375,0.411
Gastric cancer,150,0.06,0.419
Phosphatidylinositol signaling system,99,0.06060606060606061,0.421
Human papillomavirus infection,361,0.23545706371191136,0.432
Ras signaling pathway,242,0.1487603305785124,0.434
Spinocerebellar ataxia,141,0.04964539007092199,0.439
Homologous recombination,42,0.11904761904761904,0.44
ECM-receptor interaction,89,0.12359550561797752,0.457
Notch signaling pathway,63,0.1111111111111111,0.462
Complement and coagulation cascades,94,0.10638297872340426,0.468
Proteoglycans in cancer,205,0.12195121951219512,0.476
Peroxisome,87,0.04597701149425287,0.486
Malaria,57,0.10526315789473684,0.486
Oocyte meiosis,123,0.08943089430894309,0.487
Inositol phosphate metabolism,73,0.0410958904109589,0.488
Cholesterol metabolism,50,0.08,0.497
Nucleotide excision repair,58,0.25862068965517243,0.499
Protein digestion and absorption,110,0.03636363636363636,0.502
Aminoacyl-tRNA biosynthesis,84,0.03571428571428571,0.529
Leukocyte transendothelial migration,121,0.1652892561983471,0.53
Nucleocytoplasmic transport,117,0.3418803418803419,0.53
Sphingolipid signaling pathway,127,0.25984251968503935,0.534
Retrograde endocannabinoid signaling,150,0.02666666666666667,0.535
Motor proteins,196,0.09693877551020408,0.539
Chronic myeloid leukemia,76,0.19736842105263158,0.548
Chemical carcinogenesis - receptor activation,225,0.11555555555555555,0.549
RPA complex,3,1.3333333333333333,0.56
Dilated cardiomyopathy,94,0.09574468085106383,0.564
Pancreatic secretion,116,0.0603448275862069,0.566
cGMP-PKG signaling pathway,175,0.21142857142857144,0.579
Collecting duct acid secretion,27,0.1111111111111111,0.581
cAMP signaling pathway,224,0.15178571428571427,0.586
PI3K-Akt signaling pathway,373,0.225201072386059,0.587
"V-type ATPase, eukaryotes",24,0.125,0.588
Transcriptional misregulation in cancer,224,0.17857142857142858,0.592
AMPK signaling pathway,128,0.109375,0.599
Mismatch repair,22,0.36363636363636365,0.601
Pyrimidine metabolism,107,0.2336448598130841,0.603
mTOR signaling pathway,158,0.0189873417721519,0.605
Nuclear pore complex,41,0.4634146341463415,0.605
AGE-RAGE signaling pathway in diabetic complications,101,0.27722772277227725,0.608
Fc gamma R-mediated phagocytosis,97,0.32989690721649484,0.631
Rap1 signaling pathway,218,0.21100917431192662,0.632
Pathways in cancer,543,0.23756906077348067,0.633
GABAergic synapse,91,0.04395604395604396,0.651
Gastric acid secretion,75,0.08,0.656
MicroRNAs in cancer,303,0.09900990099009901,0.663
Thyroid hormone synthesis,74,0.10810810810810811,0.667
p53 signaling pathway,74,0.17567567567567569,0.669
Melanogenesis,100,0.04,0.677
Riboflavin metabolism,8,0.375,0.683
Choline metabolism in cancer,98,0.1836734693877551,0.685
Acute myeloid leukemia,70,0.18571428571428572,0.687
Fc epsilon RI signaling pathway,68,0.19117647058823528,0.697
Platelet activation,126,0.3333333333333333,0.697
"Growth hormone synthesis, secretion and action",117,0.1623931623931624,0.7
Cholinergic synapse,114,0.14035087719298245,0.703
Focal adhesion,204,0.18627450980392157,0.703
Endocrine resistance,93,0.11827956989247312,0.709
PPAR signaling pathway,90,0.08888888888888889,0.72
Salivary secretion,88,0.09090909090909091,0.721
Circadian entrainment,100,0.03,0.734
cAMP signaling,15,0.2,0.736
Morphine addiction,91,0.03296703296703297,0.74
Long-term depression,61,0.04918032786885246,0.741
Hepatocellular carcinoma,174,0.13793103448275862,0.744
Bile secretion,100,0.03,0.751
Ovarian steroidogenesis,65,0.046153846153846156,0.759
Arrhythmogenic right ventricular cardiomyopathy (ARVC),72,0.05555555555555555,0.766
Coronavirus disease - COVID-19,249,0.2570281124497992,0.769
Longevity regulating pathway - multiple species,62,0.04838709677419355,0.77
Vascular smooth muscle contraction,145,0.14482758620689656,0.774
Drug metabolism - cytochrome P450,72,0.05555555555555555,0.778
Carbohydrate digestion and absorption,49,0.061224489795918366,0.783
Glutamatergic synapse,116,0.034482758620689655,0.785
Regulation of lipolysis in adipocytes,57,0.05263157894736842,0.785
Insulin secretion,86,0.09302325581395349,0.79
Renal cell carcinoma,68,0.11764705882352941,0.79
Autophagy - animal,167,0.11377245508982035,0.793
Spliceosome,186,0.06451612903225806,0.793
Arrhythmogenic right ventricular cardiomyopathy,77,0.05194805194805195,0.793
Pancreatic cancer,76,0.2894736842105263,0.797
Ribosome,187,0.1657754010695187,0.799
VEGF signaling pathway,58,0.13793103448275862,0.817
Base excision repair,49,0.061224489795918366,0.824
Cell cycle,157,0.07643312101910828,0.824
TGF-beta signaling pathway,112,0.1875,0.825
MAPK signaling pathway,252,0.1349206349206349,0.834
GnRH signaling pathway,90,0.07777777777777778,0.84
Aldosterone synthesis and secretion,105,0.08571428571428572,0.841
Endocrine and other factor-regulated calcium reabsorption,61,0.06557377049180328,0.843
Aldosterone-regulated sodium reabsorption,39,0.20512820512820512,0.848
Ribosome biogenesis in eukaryotes,125,0.024,0.853
Regulation of actin cytoskeleton,239,0.24267782426778242,0.865
MAPK (p38) signaling,22,0.13636363636363635,0.87
Arginine and proline metabolism,57,0.08771929824561403,0.873
ABC transporters,52,0.09615384615384616,0.875
Axon guidance,183,0.1092896174863388,0.88
MAPK (JNK) signaling,21,0.14285714285714285,0.881
Metabolism of xenobiotics by cytochrome P450,75,0.04,0.885
Wnt signaling pathway,180,0.08888888888888889,0.886
Insulin signaling pathway,143,0.07692307692307693,0.889
ATP-dependent chromatin remodeling,136,0.08823529411764706,0.894
Estrogen signaling pathway,134,0.09701492537313433,0.898
Chemical carcinogenesis - DNA adducts,84,0.03571428571428571,0.905
GnRH secretion,63,0.06349206349206349,0.906
Inflammatory mediator regulation of TRP channels,127,0.07086614173228346,0.913
Purine metabolism,185,0.20540540540540542,0.914
Gap junction,86,0.09302325581395349,0.92
Non-small cell lung cancer,72,0.2361111111111111,0.922
Neuroactive ligand-receptor interaction,393,0.043256997455470736,0.936
Amyotrophic lateral sclerosis (ALS),52,0.1346153846153846,0.944
Bacterial invasion of epithelial cells,76,0.18421052631578946,0.948
"Parathyroid hormone synthesis, secretion and action",108,0.08333333333333333,0.949
Colorectal cancer,88,0.20454545454545456,0.95
Progesterone-mediated oocyte maturation,92,0.06521739130434782,0.953
Circadian rhythm,37,0.13513513513513514,0.968
Central carbon metabolism in cancer,69,0.07246376811594203,0.969
Ubiquitin mediated proteolysis,151,0.2251655629139073,0.971
Hypertrophic cardiomyopathy,91,0.04395604395604396,0.972
Mineral absorption,56,0.05357142857142857,0.975
Phospholipase D signaling pathway,150,0.16666666666666666,0.979
Type II diabetes mellitus,48,0.08333333333333333,0.987
Insulin resistance,110,0.22727272727272727,0.988
Thyroid hormone signaling pathway,120,0.13333333333333333,0.991
